Related Experiment Video
Updated: Jul 5, 2025
09:49
Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing
Published on: December 3, 2019
10.9K
Single Cell Sequencing Technology and Its Application in Alzheimer's Disease
Yuru Han1,2,3, Congying Huang1,2,3, Yuhui Pan4
1Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Journal of Alzheimer'S Disease : JAD
|January 13, 2024
Summary
Single-cell sequencing offers new ways to study Alzheimer's disease (AD) by examining individual brain cells. This technology helps overcome challenges in diagnosing and understanding AD
Area of Science:
- Neuroscience
- Genomics
- Biotechnology
Background:
- Alzheimer's disease (AD) is characterized by brain cell degeneration, often diagnosed late due to slow progression.
- Current diagnostic and treatment strategies for AD face significant challenges.
- Traditional bulk sequencing methods fail to capture the cellular heterogeneity crucial for understanding complex diseases like AD.
Purpose of the Study:
- To provide an overview of emerging single-cell sequencing technologies.
- To highlight the application of these advanced techniques in Alzheimer's disease research.
- To underscore the advantages of single-cell analysis in studying complex neurological disorders.
Main Methods:
- Review of current single-cell sequencing technologies, including transcriptomics, epigenomics, genomics, and proteomics.
- Analysis of the application of these technologies in understanding Alzheimer's disease pathogenesis.
- Discussion of the benefits of single-cell resolution for studying central nervous system complexity.
Main Results:
- Single-cell sequencing technologies provide unprecedented resolution for studying cellular heterogeneity in the brain.
- These methods offer significant advantages over traditional bulk sequencing for complex diseases.
- Rapid advancements in single-cell technologies are expanding their utility in AD research.
Conclusions:
- Single-cell sequencing is a powerful tool for unraveling the complexities of Alzheimer's disease.
- Understanding cellular heterogeneity is key to improving AD diagnosis and treatment.
- The reviewed single-cell technologies represent a significant leap forward in neurological disease research.
Related Concept Videos
03:21RNA-seq
10.0K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.0K
03:00Next-generation Sequencing
88.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.9K
01:26Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490